The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 29 (4) , 6S19-6S27
- https://doi.org/10.1016/s1262-3636(03)72784-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed DefinitionsDiabetes Care, 2003
- Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort StudyAmerican Journal of Epidemiology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Epidemiology of Peripheral Arterial DiseaseJournal of Cardiovascular Pharmacology, 1994
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Risk factors for NIDDM in white population. Paris prospective studyDiabetes, 1991
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991
- Factors affecting fasting serum C-peptide levels in Micronesians: comparison with a Caucasoid populationDiabetologia, 1984